T44.2Ganglionic blocking drugs, not elsewhere classified
Code usage status
Primary diagnosis
May be used as the primary diagnosis
Apply only when it matches the confirmed diagnosis and the documented clinical record.
Specificity
Complete code in the classification
Use when the diagnosis matches and no exclusion applies.
- Official Vietnamese name
- Ngộ độc thuốc ngăn chạn hạch [chẹn], chưa phân loại mục khác
Related T44 codes
T44
Poisoning by drugs primarily affecting the autonomic nervous system
T44.0
Primary diagnosis candidate
Anticholinesterase agents
T44.1
Primary diagnosis candidate
Other parasympathomime tics [cholinergics]
T44.3
Primary diagnosis candidate
Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
T44.4
Primary diagnosis candidate
Predominantly alpha- adrenoreceptor agonists, not elsewhere classified
T44.5
Primary diagnosis candidate
Predominantly beta- adrenoreceptor agonists, not elsewhere classified
T44.6
Primary diagnosis candidate
Alpha- adrenoreceptor antagonists, not elsewhere classified
T44.7
Primary diagnosis candidate
Beta- adrenoreceptor antagonists, not elsewhere classified
T44.8
Primary diagnosis candidate
Centrally acting and adrenergic- neuron-blocking agents, not elsewhere classified
T44.9
Primary diagnosis candidate
Other and unspecified drugs primarily affecting the autonomic nervous system
Clinical record checklist
View coding guide →- Confirm that the code matches the final documented diagnosis.
- Use one primary-diagnosis code and record only relevant additional conditions.
- Review Ministry indicators, inclusions, exclusions and notes.
- Do not infer a diagnosis beyond the clinical record.
2026 regulatory basis
Indicators are taken from columns 24–29 of the classification accompanying Circular 06/2026/TT-BYT, cross-referenced with Decision 1849/QĐ-BYT and Official Dispatch 4059/BYT-BH.
